Skip to main content
Top
Published in: Clinical & Experimental Metastasis 5/2013

Open Access 01-06-2013 | Research Paper

Increased growth of colorectal liver metastasis following partial hepatectomy

Authors: P. Krause, H. Flikweert, M. Monin, A. Seif Amir Hosseini, G. Helms, G. Cantanhede, B. M. Ghadimi, S. Koenig

Published in: Clinical & Experimental Metastasis | Issue 5/2013

Login to get access

Abstract

Nearly 50 % of colorectal cancer (CRC) patients develop liver metastases with liver resection being the only option to cure patients. Residual micrometastases or circulating tumor cells are considered a cause of tumor relapse. This work investigates the influence of partial hepatectomy (PH) on the growth and molecular composition of CRC liver metastasis in a syngeneic rat model. One million CC531 colorectal tumor cells were implanted via the portal vein in WAG/Rij rats followed by a 30 % PH a day later. Control groups either received tumor cells followed by a sham-operation or were injected with a buffer solution followed by PH. Animals were examined with magnetic resonance imaging (MRI) and liver tissues were processed for immunolabeling and PCR analysis. One-third PH was associated with an almost threefold increase in relative tumor mass (MRI volumetry: 2.8-fold and transcript levels of CD44: 2.3-fold). Expression of molecular markers for invasiveness and aggressiveness (CD49f, CXCR4, Axin2 and c-met) was increased following PH, however with no significant differences when referring to the relative expression levels (relating to tumor mass). Liver metastases demonstrated a significantly higher proliferation rate (Ki67) 2 weeks following PH and cell divisions also increased in the surrounding liver tissue. Following PH, the stimulated growth of metastases clearly exceeded the compensation in liver volume with long-lasting proliferative effects. However, the distinct tumor composition was not influenced by liver regeneration. Future investigations should focus on the inhibition of cell cycle (i.e. systemic therapy strategies, irradiation) to hinder liver regeneration and therefore restrain tumor growth.
Literature
1.
go back to reference Quan D, Gallinger S, Nhan C, Auer RA, Biagi JJ, Fletcher GG, Law CH, Moulton CA, Ruo L, Wei AC, McLeod RS (2012) The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery 151:860–870PubMedCrossRef Quan D, Gallinger S, Nhan C, Auer RA, Biagi JJ, Fletcher GG, Law CH, Moulton CA, Ruo L, Wei AC, McLeod RS (2012) The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery 151:860–870PubMedCrossRef
2.
go back to reference Felekouras ES, Kaparelos DC, Papalambros E (2012) The history of liver surgery, hepatectomy and haemostasis. Acta Chir Hell 82:280–296 Felekouras ES, Kaparelos DC, Papalambros E (2012) The history of liver surgery, hepatectomy and haemostasis. Acta Chir Hell 82:280–296
3.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249PubMedCrossRef Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249PubMedCrossRef
4.
5.
go back to reference Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474PubMedCrossRef Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474PubMedCrossRef
6.
go back to reference Cummings LC, Payes JD, Cooper GS (2007) Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 109:718–726PubMedCrossRef Cummings LC, Payes JD, Cooper GS (2007) Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 109:718–726PubMedCrossRef
7.
go back to reference Sosa MS, Avivar-Valderas A, Bragado P, Wen HC, Aguirre-Ghiso JA (2011) ERK1/2 and p38alpha/beta signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clin Cancer Res 17:5850–5857PubMedCrossRef Sosa MS, Avivar-Valderas A, Bragado P, Wen HC, Aguirre-Ghiso JA (2011) ERK1/2 and p38alpha/beta signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clin Cancer Res 17:5850–5857PubMedCrossRef
8.
go back to reference Hensel JA, Flaig TW, Theodorescu D (2012) Clinical opportunities and challenges in targeting tumour dormancy. Nat Rev Clin Oncol 10:41–51PubMedCrossRef Hensel JA, Flaig TW, Theodorescu D (2012) Clinical opportunities and challenges in targeting tumour dormancy. Nat Rev Clin Oncol 10:41–51PubMedCrossRef
9.
go back to reference Homayounfar K, Bleckmann A, Conradi LC, Sprenger T, Beissbarth T, Lorf T, Niessner M, Sahlmann CO, Meller J, Becker H, Liersch T, Ghadimi BM (2012) Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment. Int J Colorectal Dis 27:1359–1367PubMedCrossRef Homayounfar K, Bleckmann A, Conradi LC, Sprenger T, Beissbarth T, Lorf T, Niessner M, Sahlmann CO, Meller J, Becker H, Liersch T, Ghadimi BM (2012) Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment. Int J Colorectal Dis 27:1359–1367PubMedCrossRef
10.
go back to reference Koenig S, Krause P, Drabent B, Schaeffner I, Christ B, Schwartz P, Unthan-Fechner K, Probst I (2006) The expression of mesenchymal, neural and haematopoietic stem cell markers in adult hepatocytes proliferating in vitro. J Hepatol 44:1115–1124PubMedCrossRef Koenig S, Krause P, Drabent B, Schaeffner I, Christ B, Schwartz P, Unthan-Fechner K, Probst I (2006) The expression of mesenchymal, neural and haematopoietic stem cell markers in adult hepatocytes proliferating in vitro. J Hepatol 44:1115–1124PubMedCrossRef
11.
go back to reference Thomas C, Nijenhuis AM, Timens W, Kuppen PJ, Daemen T, Scherphof GL (1993) Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. Invasion Metastasis 13:102–112PubMed Thomas C, Nijenhuis AM, Timens W, Kuppen PJ, Daemen T, Scherphof GL (1993) Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. Invasion Metastasis 13:102–112PubMed
12.
go back to reference Germann A, Dihlmann S, Hergenhahn M, Doeberitz MK, Koesters R (2003) Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirin. Int J Cancer 106:187–197PubMedCrossRef Germann A, Dihlmann S, Hergenhahn M, Doeberitz MK, Koesters R (2003) Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirin. Int J Cancer 106:187–197PubMedCrossRef
13.
go back to reference Cass JD, Varma S, Day AG, Sangrar W, Rajput AB, Raptis LH, Squire J, Madarnas Y, SenGupta SK, Elliott BE (2012) Automated quantitative analysis of p53, cyclin D1, Ki67 and pERK expression in breast carcinoma does not differ from expert pathologist scoring and correlates with clinico-pathological characteristics. Cancer 4:725–742CrossRef Cass JD, Varma S, Day AG, Sangrar W, Rajput AB, Raptis LH, Squire J, Madarnas Y, SenGupta SK, Elliott BE (2012) Automated quantitative analysis of p53, cyclin D1, Ki67 and pERK expression in breast carcinoma does not differ from expert pathologist scoring and correlates with clinico-pathological characteristics. Cancer 4:725–742CrossRef
14.
go back to reference Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den Heuvel E, Goovaerts G, Dirix LY, Van Marck E (2001) Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol 195:336–342PubMedCrossRef Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den Heuvel E, Goovaerts G, Dirix LY, Van Marck E (2001) Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol 195:336–342PubMedCrossRef
15.
go back to reference Van den Eynden GG, Bird NC, Majeed AW, Van Laere S, Dirix LY, Vermeulen PB (2012) The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis 29:541–549PubMedCrossRef Van den Eynden GG, Bird NC, Majeed AW, Van Laere S, Dirix LY, Vermeulen PB (2012) The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis 29:541–549PubMedCrossRef
16.
17.
go back to reference Aussilhou B, Panis Y, Alves A, Nicco C, Klatzmann D (2008) Tumor recurrence after partial hepatectomy for liver metastases in rats: prevention by in vivo injection of irradiated cancer cells expressing GMCSF and IL-12. J Surg Res 149:184–191PubMedCrossRef Aussilhou B, Panis Y, Alves A, Nicco C, Klatzmann D (2008) Tumor recurrence after partial hepatectomy for liver metastases in rats: prevention by in vivo injection of irradiated cancer cells expressing GMCSF and IL-12. J Surg Res 149:184–191PubMedCrossRef
18.
go back to reference Wigmore SJ, Madhavan K, Redhead DN, Currie EJ, Garden OJ (2000) Distribution of colorectal liver metastases in patients referred for hepatic resection. Cancer 89:285–287PubMedCrossRef Wigmore SJ, Madhavan K, Redhead DN, Currie EJ, Garden OJ (2000) Distribution of colorectal liver metastases in patients referred for hepatic resection. Cancer 89:285–287PubMedCrossRef
19.
go back to reference Paschos KA, Canovas D, Bird NC (2010) The engagement of selectins and their ligands in colorectal cancer liver metastases. J Cell Mol Med 14:165–174PubMedCrossRef Paschos KA, Canovas D, Bird NC (2010) The engagement of selectins and their ligands in colorectal cancer liver metastases. J Cell Mol Med 14:165–174PubMedCrossRef
20.
go back to reference Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N (2012) Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Oncol Rep 28:1301–1308PubMed Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N (2012) Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Oncol Rep 28:1301–1308PubMed
21.
go back to reference Todaro M, Francipane MG, Medema JP, Stassi G (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138:2151–2162PubMedCrossRef Todaro M, Francipane MG, Medema JP, Stassi G (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138:2151–2162PubMedCrossRef
22.
go back to reference Beaulieu JF (2010) Integrin alpha6beta4 in colorectal cancer. World J Gastrointest Pathophysiol 1:3–11PubMedCrossRef Beaulieu JF (2010) Integrin alpha6beta4 in colorectal cancer. World J Gastrointest Pathophysiol 1:3–11PubMedCrossRef
23.
go back to reference Kuwada SK, Kuang J, Li X (2005) Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells. J Biol Chem 280:19027–19035PubMedCrossRef Kuwada SK, Kuang J, Li X (2005) Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells. J Biol Chem 280:19027–19035PubMedCrossRef
24.
go back to reference McDonald SL, Silver AR (2011) On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling. Colorectal Dis 13:360–369PubMedCrossRef McDonald SL, Silver AR (2011) On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling. Colorectal Dis 13:360–369PubMedCrossRef
25.
go back to reference Zugowski C, Lieder F, Muller A, Gasch J, Corvinus FM, Moriggl R, Friedrich K (2011) STAT3 controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the MMP-1 promoter. Biol Chem 392:449–459PubMedCrossRef Zugowski C, Lieder F, Muller A, Gasch J, Corvinus FM, Moriggl R, Friedrich K (2011) STAT3 controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the MMP-1 promoter. Biol Chem 392:449–459PubMedCrossRef
26.
go back to reference Tsareva SA, Moriggl R, Corvinus FM, Wiederanders B, Schutz A, Kovacic B, Friedrich K (2007) Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 9:279–291PubMedCrossRef Tsareva SA, Moriggl R, Corvinus FM, Wiederanders B, Schutz A, Kovacic B, Friedrich K (2007) Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 9:279–291PubMedCrossRef
27.
go back to reference Martins PN, Theruvath TP, Neuhaus P (2008) Rodent models of partial hepatectomies. Liver Int 28:3–11PubMedCrossRef Martins PN, Theruvath TP, Neuhaus P (2008) Rodent models of partial hepatectomies. Liver Int 28:3–11PubMedCrossRef
28.
go back to reference Harun N, Nikfarjam M, Muralidharan V, Christophi C (2007) Liver regeneration stimulates tumor metastases. J Surg Res 138:284–290PubMedCrossRef Harun N, Nikfarjam M, Muralidharan V, Christophi C (2007) Liver regeneration stimulates tumor metastases. J Surg Res 138:284–290PubMedCrossRef
29.
go back to reference Nakashima Y, Ono T, Yamanoi A, El-Assal ON, Kohno H, Nagasue N (2004) Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Gastroenterol 39:763–768PubMedCrossRef Nakashima Y, Ono T, Yamanoi A, El-Assal ON, Kohno H, Nagasue N (2004) Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Gastroenterol 39:763–768PubMedCrossRef
30.
go back to reference Picardo A, Karpoff HM, Ng B, Lee J, Brennan MF, Fong Y (1998) Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 124:57–64PubMedCrossRef Picardo A, Karpoff HM, Ng B, Lee J, Brennan MF, Fong Y (1998) Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 124:57–64PubMedCrossRef
31.
go back to reference Slooter GD, Marquet RL, Jeekel J, Ijzermans JN (1995) Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha. Br J Surg 82:129–132PubMedCrossRef Slooter GD, Marquet RL, Jeekel J, Ijzermans JN (1995) Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha. Br J Surg 82:129–132PubMedCrossRef
32.
go back to reference Koh SL, Ager EI, Christophi C (2010) Liver regeneration and tumour stimulation: implications of the renin-angiotensin system. Liver Int 30:1414–1426PubMedCrossRef Koh SL, Ager EI, Christophi C (2010) Liver regeneration and tumour stimulation: implications of the renin-angiotensin system. Liver Int 30:1414–1426PubMedCrossRef
33.
go back to reference de Jong KP, Lont HE, Bijma AM, Brouwers MA, de Vries EG, van Veen ML, Marquet RL, Slooff MJ, Terpstra OT (1995) The effect of partial hepatectomy on tumor growth in rats: in vivo and in vitro studies. Hepatology 22:1263–1272PubMedCrossRef de Jong KP, Lont HE, Bijma AM, Brouwers MA, de Vries EG, van Veen ML, Marquet RL, Slooff MJ, Terpstra OT (1995) The effect of partial hepatectomy on tumor growth in rats: in vivo and in vitro studies. Hepatology 22:1263–1272PubMedCrossRef
34.
go back to reference de Jong KP, Slooff MJ, de Vries EG, Brouwers MA, Terpstra OT (1996) Effect of partial liver resection on tumour growth. J Hepatol 25:109–121PubMedCrossRef de Jong KP, Slooff MJ, de Vries EG, Brouwers MA, Terpstra OT (1996) Effect of partial liver resection on tumour growth. J Hepatol 25:109–121PubMedCrossRef
35.
go back to reference Palmucci S, Mauro LA, Messina M, Russo B, Failla G, Milone P, Berretta M, Ettorre GC (2012) Diffusion-weighted MRI in a liver protocol: its role in focal lesion detection. World J Radiol 4:302–310PubMedCrossRef Palmucci S, Mauro LA, Messina M, Russo B, Failla G, Milone P, Berretta M, Ettorre GC (2012) Diffusion-weighted MRI in a liver protocol: its role in focal lesion detection. World J Radiol 4:302–310PubMedCrossRef
37.
go back to reference Shcherbo D, Murphy CS, Ermakova GV, Solovieva EA, Chepurnykh TV, Shcheglov AS, Verkhusha VV, Pletnev VZ, Hazelwood KL, Roche PM, Lukyanov S, Zaraisky AG, Davidson MW, Chudakov DM (2009) Far-red fluorescent tags for protein imaging in living tissues. Biochem J 418:567–574PubMedCrossRef Shcherbo D, Murphy CS, Ermakova GV, Solovieva EA, Chepurnykh TV, Shcheglov AS, Verkhusha VV, Pletnev VZ, Hazelwood KL, Roche PM, Lukyanov S, Zaraisky AG, Davidson MW, Chudakov DM (2009) Far-red fluorescent tags for protein imaging in living tissues. Biochem J 418:567–574PubMedCrossRef
38.
go back to reference Wessels JT, Busse AC, Mahrt J, Dullin C, Grabbe E, Mueller GA (2007) In vivo imaging in experimental preclinical tumor research: a review. Cytometry A 71:542–549PubMed Wessels JT, Busse AC, Mahrt J, Dullin C, Grabbe E, Mueller GA (2007) In vivo imaging in experimental preclinical tumor research: a review. Cytometry A 71:542–549PubMed
39.
go back to reference Ikeda Y, Matsumata T, Takenaka K, Sasaki O, Soejima K, Sugimachi K (1995) Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur J Surg Oncol 21:188–190PubMedCrossRef Ikeda Y, Matsumata T, Takenaka K, Sasaki O, Soejima K, Sugimachi K (1995) Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur J Surg Oncol 21:188–190PubMedCrossRef
41.
go back to reference Panis Y, Nordlinger B, Delelo R, Herve JP, Infante J, Kuhnle M, Ballet F (1990) Experimental colorectal liver metastases. Influence of sex, immunological status and liver regeneration. J Hepatol 11:53–57PubMedCrossRef Panis Y, Nordlinger B, Delelo R, Herve JP, Infante J, Kuhnle M, Ballet F (1990) Experimental colorectal liver metastases. Influence of sex, immunological status and liver regeneration. J Hepatol 11:53–57PubMedCrossRef
42.
go back to reference Panis Y, Ribeiro J, Chretien Y, Nordlinger B (1992) Dormant liver metastases: an experimental study. Br J Surg 79:221–223PubMedCrossRef Panis Y, Ribeiro J, Chretien Y, Nordlinger B (1992) Dormant liver metastases: an experimental study. Br J Surg 79:221–223PubMedCrossRef
43.
go back to reference Doerr R, Castillo M, Evans P, Paolini N, Goldrosen M, Cohen SA (1989) Partial hepatectomy augments the liver’s antitumor response. Arch Surg 124:170–174PubMedCrossRef Doerr R, Castillo M, Evans P, Paolini N, Goldrosen M, Cohen SA (1989) Partial hepatectomy augments the liver’s antitumor response. Arch Surg 124:170–174PubMedCrossRef
44.
go back to reference Ono M, Tanaka N, Orita K (1986) Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res 46:5049–5053PubMed Ono M, Tanaka N, Orita K (1986) Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res 46:5049–5053PubMed
45.
go back to reference Morikawa S, Murayama H, Fujimoto S, Shiino A, Inubushi T (2012) A simple way to acquire T(1)-weighted MR images of rat liver with respiratory triggering. Magn Reson Imaging 30:453–458PubMedCrossRef Morikawa S, Murayama H, Fujimoto S, Shiino A, Inubushi T (2012) A simple way to acquire T(1)-weighted MR images of rat liver with respiratory triggering. Magn Reson Imaging 30:453–458PubMedCrossRef
46.
go back to reference Kaufels N, Korn R, Wagner S, Schink T, Hamm B, Taupitz M, Schnorr J (2008) Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases. Invest Radiol 43:496–503PubMedCrossRef Kaufels N, Korn R, Wagner S, Schink T, Hamm B, Taupitz M, Schnorr J (2008) Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases. Invest Radiol 43:496–503PubMedCrossRef
47.
go back to reference Wack C, Steger-Hartmann T, Mylecraine L, Hofmeister R (2012) Toxicological safety evaluation of gadobutrol. Invest Radiol 47:611–623PubMedCrossRef Wack C, Steger-Hartmann T, Mylecraine L, Hofmeister R (2012) Toxicological safety evaluation of gadobutrol. Invest Radiol 47:611–623PubMedCrossRef
48.
go back to reference Partecke IL, Kaeding A, Sendler M, Albers N, Kuhn JP, Speerforck S, Roese S, Seubert F, Diedrich S, Kuehn S, Weiss UF, Mayerle J, Lerch MM, Hadlich S, Hosten N, Heidecke CD, Puls R, von Bernstorff W (2011) In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model. BMC Cancer 11:40PubMedCrossRef Partecke IL, Kaeding A, Sendler M, Albers N, Kuhn JP, Speerforck S, Roese S, Seubert F, Diedrich S, Kuehn S, Weiss UF, Mayerle J, Lerch MM, Hadlich S, Hosten N, Heidecke CD, Puls R, von Bernstorff W (2011) In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model. BMC Cancer 11:40PubMedCrossRef
49.
go back to reference Voth M, Rosenberg M, Breuer J (2011) Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance. Invest Radiol 46:663–671PubMed Voth M, Rosenberg M, Breuer J (2011) Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance. Invest Radiol 46:663–671PubMed
50.
go back to reference Katoh M (2008) WNT signaling in stem cell biology and regenerative medicine. Curr Drug Targets 9:565–570PubMedCrossRef Katoh M (2008) WNT signaling in stem cell biology and regenerative medicine. Curr Drug Targets 9:565–570PubMedCrossRef
51.
go back to reference Oliveira Frick V, Rubie C, Ghadjar P, Faust SK, Wagner M, Graber S, Schilling MK (2011) Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies. Tumour Biol 32:189–196PubMedCrossRef Oliveira Frick V, Rubie C, Ghadjar P, Faust SK, Wagner M, Graber S, Schilling MK (2011) Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies. Tumour Biol 32:189–196PubMedCrossRef
52.
go back to reference Osada S, Matsui S, Komori S, Yamada J, Sanada Y, Ihawa A, Tanaka Y, Tokuyama Y, Okumura N, Nonaka K, Hosono Y, Takahashi T, Yamaguchi K, Yoshida K (2010) Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer. Hepatogastroenterology 57:76–80PubMed Osada S, Matsui S, Komori S, Yamada J, Sanada Y, Ihawa A, Tanaka Y, Tokuyama Y, Okumura N, Nonaka K, Hosono Y, Takahashi T, Yamaguchi K, Yoshida K (2010) Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer. Hepatogastroenterology 57:76–80PubMed
53.
go back to reference Li W, Liang X, Kellendonk C, Poli V, Taub R (2002) STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277:28411–28417PubMedCrossRef Li W, Liang X, Kellendonk C, Poli V, Taub R (2002) STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277:28411–28417PubMedCrossRef
54.
go back to reference Paschos KA, Bird NC (2010) Liver regeneration and its impact on post-hepatectomy metastatic tumour recurrence. Anticancer Res 30:2161–2170PubMed Paschos KA, Bird NC (2010) Liver regeneration and its impact on post-hepatectomy metastatic tumour recurrence. Anticancer Res 30:2161–2170PubMed
55.
go back to reference Koenig S, Krause P, Schmidt TK, Rave-Fraenk M, Rothe H, Hermann RM, Becker H, Hess CF, Christiansen H (2008) Irradiation as preparative regimen for hepatocyte transplantation causes prolonged cell cycle block. Int J Radiat Biol 84:285–298PubMedCrossRef Koenig S, Krause P, Schmidt TK, Rave-Fraenk M, Rothe H, Hermann RM, Becker H, Hess CF, Christiansen H (2008) Irradiation as preparative regimen for hepatocyte transplantation causes prolonged cell cycle block. Int J Radiat Biol 84:285–298PubMedCrossRef
56.
go back to reference de Jong GM, Hendriks T, Eek A, Oyen WJ, Heskamp S, Bleichrodt RP, Boerman OC (2009) Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin. Ann Surg Oncol 16:2065–2073PubMedCrossRef de Jong GM, Hendriks T, Eek A, Oyen WJ, Heskamp S, Bleichrodt RP, Boerman OC (2009) Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin. Ann Surg Oncol 16:2065–2073PubMedCrossRef
57.
go back to reference de Jong GM, Hendriks T, Eek A, Oyen WJ, Nagtegaal ID, Bleichrodt RP, Boerman OC (2011) Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases. Ann Surg 253:336–341PubMedCrossRef de Jong GM, Hendriks T, Eek A, Oyen WJ, Nagtegaal ID, Bleichrodt RP, Boerman OC (2011) Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases. Ann Surg 253:336–341PubMedCrossRef
58.
go back to reference Juez I, Rubio C, Figueras J (2011) Multidisciplinary approach of colorectal liver metastases. Clin Transl Oncol 13:721–727PubMedCrossRef Juez I, Rubio C, Figueras J (2011) Multidisciplinary approach of colorectal liver metastases. Clin Transl Oncol 13:721–727PubMedCrossRef
Metadata
Title
Increased growth of colorectal liver metastasis following partial hepatectomy
Authors
P. Krause
H. Flikweert
M. Monin
A. Seif Amir Hosseini
G. Helms
G. Cantanhede
B. M. Ghadimi
S. Koenig
Publication date
01-06-2013
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 5/2013
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-013-9572-y

Other articles of this Issue 5/2013

Clinical & Experimental Metastasis 5/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine